Cargando…
Development of APE1 enzymatic DNA repair assays: low APE1 activity is associated with increase lung cancer risk
The key role of DNA repair in removing DNA damage and minimizing mutations makes it an attractive target for cancer risk assessment and prevention. Here we describe the development of a robust assay for apurinic/apyrimidinic (AP) endonuclease 1 (APE1; APEX1), an essential enzyme involved in the repa...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4552243/ https://www.ncbi.nlm.nih.gov/pubmed/26045303 http://dx.doi.org/10.1093/carcin/bgv082 |
_version_ | 1782387700183072768 |
---|---|
author | Sevilya, Ziv Leitner-Dagan, Yael Pinchev, Mila Kremer, Ran Elinger, Dalia Lejbkowicz, Flavio Rennert, Hedy S. Freedman, Laurence S. Rennert, Gad Paz-Elizur, Tamar Livneh, Zvi |
author_facet | Sevilya, Ziv Leitner-Dagan, Yael Pinchev, Mila Kremer, Ran Elinger, Dalia Lejbkowicz, Flavio Rennert, Hedy S. Freedman, Laurence S. Rennert, Gad Paz-Elizur, Tamar Livneh, Zvi |
author_sort | Sevilya, Ziv |
collection | PubMed |
description | The key role of DNA repair in removing DNA damage and minimizing mutations makes it an attractive target for cancer risk assessment and prevention. Here we describe the development of a robust assay for apurinic/apyrimidinic (AP) endonuclease 1 (APE1; APEX1), an essential enzyme involved in the repair of oxidative DNA damage. APE1 DNA repair enzymatic activity was measured in peripheral blood mononuclear cell protein extracts using a radioactivity-based assay, and its association with lung cancer was determined using conditional logistic regression with specimens from a population-based case–control study with 96 lung cancer cases and 96 matched control subjects. The mean APE1 enzyme activity in case patients was 691 [95% confidence interval (CI) = 655–727] units/ng protein, significantly lower than in control subjects (mean = 793, 95% CI = 751–834 units/ng protein, P = 0.0006). The adjusted odds ratio for lung cancer associated with 1 SD (211 units) decrease in APE1 activity was 2.0 (95% CI = 1.3–3.1; P = 0.002). Comparison of radioactivity- and fluorescence-based assays showed that the two are equivalent, indicating no interference by the fluorescent tag. The APE1Asp148Glu SNP was associated neither with APE1 enzyme activity nor with lung cancer risk. Taken together, our results indicate that low APE1 activity is associated with lung cancer risk, consistent with the hypothesis that ‘bad DNA repair’, rather than ‘bad luck’, is involved in cancer etiology. Such assays may be useful, along with additional DNA repair biomarkers, for risk assessment of lung cancer and perhaps other cancers, and for selecting individuals to undergo early detection techniques such as low-dose CT. |
format | Online Article Text |
id | pubmed-4552243 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | Oxford University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-45522432015-08-31 Development of APE1 enzymatic DNA repair assays: low APE1 activity is associated with increase lung cancer risk Sevilya, Ziv Leitner-Dagan, Yael Pinchev, Mila Kremer, Ran Elinger, Dalia Lejbkowicz, Flavio Rennert, Hedy S. Freedman, Laurence S. Rennert, Gad Paz-Elizur, Tamar Livneh, Zvi Carcinogenesis Original Manuscript The key role of DNA repair in removing DNA damage and minimizing mutations makes it an attractive target for cancer risk assessment and prevention. Here we describe the development of a robust assay for apurinic/apyrimidinic (AP) endonuclease 1 (APE1; APEX1), an essential enzyme involved in the repair of oxidative DNA damage. APE1 DNA repair enzymatic activity was measured in peripheral blood mononuclear cell protein extracts using a radioactivity-based assay, and its association with lung cancer was determined using conditional logistic regression with specimens from a population-based case–control study with 96 lung cancer cases and 96 matched control subjects. The mean APE1 enzyme activity in case patients was 691 [95% confidence interval (CI) = 655–727] units/ng protein, significantly lower than in control subjects (mean = 793, 95% CI = 751–834 units/ng protein, P = 0.0006). The adjusted odds ratio for lung cancer associated with 1 SD (211 units) decrease in APE1 activity was 2.0 (95% CI = 1.3–3.1; P = 0.002). Comparison of radioactivity- and fluorescence-based assays showed that the two are equivalent, indicating no interference by the fluorescent tag. The APE1Asp148Glu SNP was associated neither with APE1 enzyme activity nor with lung cancer risk. Taken together, our results indicate that low APE1 activity is associated with lung cancer risk, consistent with the hypothesis that ‘bad DNA repair’, rather than ‘bad luck’, is involved in cancer etiology. Such assays may be useful, along with additional DNA repair biomarkers, for risk assessment of lung cancer and perhaps other cancers, and for selecting individuals to undergo early detection techniques such as low-dose CT. Oxford University Press 2015-09 2015-06-04 /pmc/articles/PMC4552243/ /pubmed/26045303 http://dx.doi.org/10.1093/carcin/bgv082 Text en © The Author 2015. Published by Oxford University Press. http://creativecommons.org/licenses/by-nc/4.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com |
spellingShingle | Original Manuscript Sevilya, Ziv Leitner-Dagan, Yael Pinchev, Mila Kremer, Ran Elinger, Dalia Lejbkowicz, Flavio Rennert, Hedy S. Freedman, Laurence S. Rennert, Gad Paz-Elizur, Tamar Livneh, Zvi Development of APE1 enzymatic DNA repair assays: low APE1 activity is associated with increase lung cancer risk |
title | Development of APE1 enzymatic DNA repair assays: low APE1 activity is associated with increase lung cancer risk |
title_full | Development of APE1 enzymatic DNA repair assays: low APE1 activity is associated with increase lung cancer risk |
title_fullStr | Development of APE1 enzymatic DNA repair assays: low APE1 activity is associated with increase lung cancer risk |
title_full_unstemmed | Development of APE1 enzymatic DNA repair assays: low APE1 activity is associated with increase lung cancer risk |
title_short | Development of APE1 enzymatic DNA repair assays: low APE1 activity is associated with increase lung cancer risk |
title_sort | development of ape1 enzymatic dna repair assays: low ape1 activity is associated with increase lung cancer risk |
topic | Original Manuscript |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4552243/ https://www.ncbi.nlm.nih.gov/pubmed/26045303 http://dx.doi.org/10.1093/carcin/bgv082 |
work_keys_str_mv | AT sevilyaziv developmentofape1enzymaticdnarepairassayslowape1activityisassociatedwithincreaselungcancerrisk AT leitnerdaganyael developmentofape1enzymaticdnarepairassayslowape1activityisassociatedwithincreaselungcancerrisk AT pinchevmila developmentofape1enzymaticdnarepairassayslowape1activityisassociatedwithincreaselungcancerrisk AT kremerran developmentofape1enzymaticdnarepairassayslowape1activityisassociatedwithincreaselungcancerrisk AT elingerdalia developmentofape1enzymaticdnarepairassayslowape1activityisassociatedwithincreaselungcancerrisk AT lejbkowiczflavio developmentofape1enzymaticdnarepairassayslowape1activityisassociatedwithincreaselungcancerrisk AT rennerthedys developmentofape1enzymaticdnarepairassayslowape1activityisassociatedwithincreaselungcancerrisk AT freedmanlaurences developmentofape1enzymaticdnarepairassayslowape1activityisassociatedwithincreaselungcancerrisk AT rennertgad developmentofape1enzymaticdnarepairassayslowape1activityisassociatedwithincreaselungcancerrisk AT pazelizurtamar developmentofape1enzymaticdnarepairassayslowape1activityisassociatedwithincreaselungcancerrisk AT livnehzvi developmentofape1enzymaticdnarepairassayslowape1activityisassociatedwithincreaselungcancerrisk |